Long-term use of colchicine: “The time to guard against chronic toxicity among patients of familial Mediterranean fever”
Abstract Colchicine is a cheap easily available and accessible drug that has been tried in different diseases which are not limited to gout, familial Mediterranean fever (FMF), Behcet’s disease, and constipation, and has recently been tried for the treatment of COVID-19 and heart diseases. There are...
Main Authors: | Mohamed H. Emara, Abeer Hussein Abdelkader, Mohamed Said Radwan, Hassan E. Elbatae, Maysaa A. Saeed |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-04-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-023-00188-8 |
Similar Items
-
Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
by: Burcu Bozkaya Yücel, et al.
Published: (2021-09-01) -
Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
by: Ali Şahin, et al.
Published: (2020-01-01) -
Anakinra induces complete remission of nephrotic syndrome in a patient with familial Mediterranean fever and amyloidosis
by: Ángel M. Sevillano, et al.
Published: (2016-01-01) -
Factors Affecting Colchicine Adherence in Pediatric Familial Mediterranean Fever
by: Esra Nagehan Akyol Önder, et al.
Published: (2023-03-01) -
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
by: Georges El Hasbani, et al.
Published: (2019-10-01)